Trademark: 97576906
Word
CHEMILOGIC
Status
Pending
Status Code
730
Status Date
Thursday, April 11, 2024
Serial Number
97576906
Mark Type
4000
Filing Date
Friday, September 2, 2022
Published for Opposition
Tuesday, August 22, 2023

Trademark Owner History
Empress Therapeutics, Inc. - Owner At Publication

Classifications
5 Pharmaceuticals containing small molecules for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; pharmaceutical preparations and therapeutic agents for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
42 Pharmaceutical drug development services; scientific research, namely, research and analysis services in the fields of pharmaceuticals and biotechnology for the design and characterization of biologic therapeutic products; pharmaceutical and biotechnology research and development

Trademark Events
Apr 11, 2024
Sou Extension 1 Granted
Apr 11, 2024
Sou Extension 1 Filed
Apr 11, 2024
Sou Teas Extension Received
Oct 17, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 22, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 22, 2023
Published For Opposition
Aug 2, 2023
Notification Of Notice Of Publication E-Mailed
Jul 20, 2023
Approved For Pub - Principal Register
Jul 19, 2023
Teas/Email Correspondence Entered
Jul 19, 2023
Correspondence Received In Law Office
Jul 19, 2023
Teas Response To Office Action Received
Jun 21, 2023
Notification Of Non-Final Action E-Mailed
Jun 21, 2023
Non-Final Action E-Mailed
Jun 21, 2023
Non-Final Action Written
Jun 20, 2023
Assigned To Examiner
Sep 21, 2022
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24